Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Luo, Yang  [Clear All Filters]
2024
Liu Y, Du L, Zhang H, Li G, Luo Y, Hu Z, Xu R, Yao J, Shi Z, Chen Y, et al. Bioprinted biomimetic hydrogel matrices guiding stem cell aggregates for enhanced chondrogenesis and cartilage regeneration. J Mater Chem B. 2024.
Zhang H, Luo Y, Hu Z, Chen M, Chen S, Yao Y, Yao J, Shao X, Wu K, Zhu Y, et al. Cation-crosslinked κ-carrageenan sub-microgel medium for high-quality embedded bioprinting. Biofabrication. 2024.
2023
Lin M, Xu Q, Luo Y, Liu G, Hou P. Bakuchiol inhibits lung cancer by modulating tumor microenvironment and the expression of PD-L1. J Biochem Mol Toxicol. 2023:e23401.
Hu Z, Luo Y, Ni R, Hu Y, Yang F, Du T, Zhu Y. Biological importance of human amniotic membrane in tissue engineering and regenerative medicine. Mater Today Bio. 2023;22:100790.
Hou P, Luo Y, Wu N. TCL1A+ B cells predict prognosis in triple-negative breast cancer through integrative analysis of single-cell and bulk transcriptomic data. Open Life Sci. 2023;18(1):20220707.
Wei X, Cheng X, Luo Y, Li X. Umbilical Cord-Derived Mesenchymal Stem Cells Attenuate S100-Induced Autoimmune Hepatitis via Modulating Th1 and Th17 Cell Responses in Mice. Stem Cells Int. 2023;2023:9992207.
2021
Liu X, Zhu R, Luo Y, Wang S, Zhao Y, Qiu Z, Zhang Y, Liu X, Yao X, Li X, et al. Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. Immunity. 2021.
Liu G, Luo Y, Hou P. Enhances Resistance to Cisplatin via Facilitating Exosomes-mediated Macrophage M2 Polarization in Non-small Cell Lung Cancer. Immunol Invest. 2021:1-14.
Fang H, Huang Y, Luo Y, Tang J, Yu M, Zhang Y, Zhong M. SIRT1 induces the accumulation of TAMs at colorectal cancer tumor sites via the CXCR4/CXCL12 axis. Cell Immunol. 2021;371:104458.
2018
Yu M, Luo Y, Cong Z, Mu Y, Qiu Y, Zhong M. MicroRNA-590-5p Inhibits Intestinal Inflammation by Targeting YAP. J Crohns Colitis. 2018.
2016
Zhu Y-T, Pang S-Y, Luo Y, Chen W, Bao J-M, Tan W-L. A modified method by differential adhesion for enrichment of bladder cancer stem cells. Int Braz J Urol. 2016;42(4):817-824.
2015
Zhu Y-T, Pang S-Y, Lei C-Y, Luo Y, Chu Q-J, Tan W-L. Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine. Stem Cell Res Ther. 2015;6(1):224.